CRL Jul 2024 130.000 put
| Previous close | 3.1200 |
| Open | 3.1200 |
| Bid | 0.6000 |
| Ask | 2.2000 |
| Strike | 130.00 |
| Expiry date | 2024-07-19 |
| Day's range | 3.1200 - 3.1200 |
| Contract range | N/A |
| Volume | |
| Open interest | 10 |
ZacksCharles River (CRL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Charles River (CRL) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- Reuters
Charles River beats first-quarter estimates, reaffirms annual forecast
Charles River Laboratories beat Wall Street estimates for first-quarter profit and revenue on Thursday, helped by strength in its manufacturing business and its unit that supplies research models to biotech clients. The contract research firm reaffirmed its full-year 2024 forecast, as it expects demand for its services to improve modestly during the second half of the year. Charles River and its peers have been grappling with weakening demand for their services due to a funding crunch among their biotech clients.
Business WireCharles River Laboratories Announces First-Quarter 2024 Results
WILMINGTON, Mass., May 09, 2024--Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2024. For the quarter, revenue was $1.01 billion, a decrease of 1.7% from $1.03 billion in the first quarter of 2023.
